Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The dopamine transporter (DAT) is a membrane glycoprotein responsible for dopamine (DA) uptake, which has been involved in the degeneration of DA cells in Parkinson's disease (PD). Given that DAT activity depends on its glycosylation status and membrane expression, and that not all midbrain DA cells show the same susceptibility to degeneration in PD, we have investigated a possible relationship between DAT glycosylation and function and the differential vulnerability of DA cells. Glycosylated DAT expression, DA uptake, and DAT V(max) were significantly higher in terminals of nigrostriatal neurons than in those of mesolimbic neurons. No differences were found in non-glycosylated DAT expression and DAT K(m), and DA uptake differences disappeared after deglycosylation of nigrostriatal synaptosomes. The expression pattern of glycosylated DAT in the human midbrain and striatum showed a close anatomical relationship with DA degeneration in parkinsonian patients. This relationship was confirmed in rodent and monkey models of PD, and in HEK cells expressing the wild-type and a partially deglycosylated DAT form. These results strongly suggest that DAT glycosylation is involved in the differential vulnerability of midbrain DA cells in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405 · cited 1×
“Glycosylation is a co- and posttranslational process that engages numerous enzymes which add glycans to newly synthesized proteins, with enzymes working in DAT glycosylation also being used in the glycosylation of other membrane-associated proteins (Melikian et al., 1996; Helenius and Aebi, 2001).”
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 2×
“…of mesostriatal projections (Fallon and Loughlin, 1982; Joel and Weiner, 2000) and their degeneration pattern in PD (Bernheimer et al., 1973; Hirsch et al., 1988; Damier et al., 1999b) and in monkey (Burns et al., 1983; German et al., 1992) and rodent (Hung and Lee, 1996; Rodriguez et al.,…”
Surmeier, D. J., Ding, J., Day, M., Wang, Z., & Shen, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.008 · Cited by 1,203 · cited 1×
“Physiological studies show that DA is involved in long-lasting activity-dependent changes in the excitatory synaptic efficacy, a cellular mechanism required for information storage in different brain regions (Calabresi et al., 2007; Surmeier et al., 2007).”
Dopamine-mediated regulation of corticostriatal synaptic plasticity
Calabresi, P., Picconi, B., Tozzi, A., & Di Filippo, M. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.001 · Cited by 865
Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803
Joel, D., & Weiner, I. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00575-8 · Cited by 614 · cited 3×
“With respect to the striatal division, according to hodological criteria, and in agreement with Fallon and Loughlin, (1982), Joel and Weiner (2000), and Heimer (2003), we considered the dSt as being composed of the two dorsal thirds of the dorsal striatum, and the vSt as being composed of the…”
Chung, C. Y., Seo, H., Sonntag, K. C., Brooks, A., Lin, L., & Isacson, O. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi178 · Cited by 361
Neural mechanisms of reward-related motor learning
Wickens, J. R., Reynolds, J. N., & Hyland, B. I. (2003) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2003.10.013 · Cited by 284
Schott, B. H., Seidenbecher, C. I., Fenker, D. B., Lauer, C. J., Bunzeck, N., Bernstein, H.-G., Tischmeyer, W., Gundelfinger, E. D., Heinze, H.-J., & Düzel, E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3463-05.2006 · Cited by 214 · cited 1×
“A rabbit polyclonal antibody against amino acids 541– 620 at the carboxy terminus of the human DAT (Santa Cruz Biotechnology, Santa Cruz, CA; sc-14002; Schott et al., 2006) which shares 91% homology with the same region of rat DAT and shows a solid band at 50 kDa and a faint band at ∼80 kDa (Fig.”
WICKENS, J. R., BUDD, C. S., HYLAND, B. I., & ARBUTHNOTT, G. W. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1390.016 · Cited by 165
Cited by
Development, wiring and function of dopamine neuron subtypes
Garritsen, O., van Battum, E. Y., Grossouw, L. M., & Pasterkamp, R. J. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00669-3 · Cited by 128
Di Salvio, M., Di Giovannantonio, L. G., Acampora, D., Prosperi, R., Omodei, D., Prakash, N., Wurst, W., & Simeone, A. (2010) · Nature Neuroscience · doi:10.1038/nn.2661 · Cited by 118
A descending dopamine pathway conserved from basal vertebrates to mammals
Ryczko, D., Cone, J. J., Alpert, M. H., Goetz, L., Auclair, F., Dubé, C., Parent, M., Roitman, M. F., Alford, S., & Dubuc, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600684113 · Cited by 101
“This is supported by a recent study in the rat, where the two antibodies were shown to selectively label dopaminergic neurons and terminals, and produce very similar patterns of labeling (79).”
Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
González-Hernández, T. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00140 · Cited by 65
Function and developmental origin of a mesocortical inhibitory circuit
Kabanova, A., Pabst, M., Lorkowski, M., Braganza, O., Boehlen, A., Nikbakht, N., Pothmann, L., Vaswani, A. R., Musgrove, R., Di Monte, D. A., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4020 · Cited by 61
Metadata
- Authors
- Afonso-Oramas, D., Cruz-Muros, I., de la Rosa, D. Á., Abreu, P., Giráldez, T., Castro-Hernández, J., Salas-Hernández, J., Lanciego, J. L., Rodríguez, M., & González-Hernández, T.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 36
- Issue
- 3
- Pages
- 494-508
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2047818394
- Cited by
- 70
- References
- 10
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease. https://app.cochat.ai/papers/10.1016/j.nbd.2009.09.002
- The paper
- Afonso-Oramas, D., Cruz-Muros, I., de la Rosa, D. Á., Abreu, P., Giráldez, T., Castro-Hernández, J., Salas-Hernández, J., Lanciego, J. L., Rodríguez, M., & González-Hernández, T. (2009). Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2009.09.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.